omega-n-methylarginine has been researched along with theanine in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (theanine) | Trials (theanine) | Recent Studies (post-2010) (theanine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 486 | 70 | 360 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Di, X; Shi, Z; Yan, J; Zhang, J; Zhao, B; Zhao, Y | 1 |
1 other study(ies) available for omega-n-methylarginine and theanine
| Article | Year |
|---|---|
L-theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Apoptosis; Calcium; Caspase 3; Cell Line, Tumor; Cell Survival; Dizocilpine Maleate; Glutamates; Glutamic Acid; Humans; JNK Mitogen-Activated Protein Kinases; Mutation; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptide Fragments; Phosphorylation; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Transgenes | 2010 |